NCT03993223

Upper Trapezius Myofascial Trigger Point in Overhead Athletes After Upper Trapezius Muscle Fatigue

Completed Phase 3 Last updated 2 March 2022

What this trial tests

Phase 3 trial testing Upper trapezius muscle fatigue in Myofascial Trigger Point Pain in 60 participants. Completed in 28 February 2022.

Timeline

17 June 2019

Primary endpoint
31 May 2021

28 February 2022

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	60
Start date	17 June 2019
Primary completion	31 May 2021
Estimated completion	28 February 2022
Sites	1 location across Taiwan

Drugs / interventions tested

• Upper trapezius muscle fatigue

Conditions studied

• Myofascial Trigger Point Pain — all drugs for Myofascial Trigger Point Pain →
• Fatigue — all drugs for Fatigue →

Sponsor

National Taiwan University Hospital

Who can join

Adults 18 to 50, any sex, with Myofascial Trigger Point Pain or Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The healthy overhead athletes with and without upper trapezius myofascial trigger point will be asked to perform a scapular elevation task until the upper trapezius muscle fatigue. The first hypothesis is that the subjects with upper trapezius myofascial trigger point will show significant difference in scapular kinematics and muscles activities when compared to subjects without upper trapezius myofascial trigger point. Besides, the investigators suggest that subjects with/without upper trapezius myofascial trigger point will show significant difference in scapular kinematics and muscles activities after upper trapezius muscle fatigue, especially in subjects with upper trapezius myofascial trigger point.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.